HAVCR2 and non-Hodgkin lymphoma: An increase in T cells expressing ISMs—PD-1, TIM-3, CTLA-4 etc.—was detected in classical Hodgkin lymphoma (HL), several non-Hodgkin lymphomas (NHL) and MM5–8.